Different doses of corticosteroid in local knee injection for total knee replacement
Official title: Prospective Randomized Controlled Trial Comparing Different Doses of Corticosteroids in Local Infiltration Analgesia (LIA) for Total Knee Arthroplasty
Run by First Affiliated Hospital of Fujian Medical University · NCT07337772 · Data updated 2026-11-12
This will test whether adding different doses of Diprospan to the local pain injection given during primary unilateral total knee replacement reduces postoperative pain and improves early recovery.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 100 Years |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | First Affiliated Hospital of Fujian Medical University Academic / other |
| Locations | 1 site (Fuzhou, Fujian) |
| Status | Recruiting |
| Started | February 1, 2026 |
| Main results expected | November 1, 2028 |
| Study ends | November 1, 2028 |
| Registry record updated | January 13, 2026 |
| Trial ID | NCT07337772 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older with unilateral knee osteoarthritis scheduled for primary unilateral total knee arthroplasty at the study hospital, with ASA physical status 1–3 and ability to give informed consent.
✕Probably not a fit
Patients with prior surgery or infection in the operative knee, non-osteoarthritis diagnoses, severe deformity, allergy to study drugs, ipsilateral neuromuscular dysfunction, or high opioid dependence are excluded and are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Researchers at the First Affiliated Hospital of Fujian Medical University are conducting a prospective, single-center, randomized controlled trial comparing different doses of the glucocorticoid Diprospan when added to local infiltration analgesia (LIA) during primary unilateral total knee arthroplasty for osteoarthritis. Eligible adults (ASA 1–3) will be randomly assigned to receive LIA with varying Diprospan doses at the time of surgery, and outcomes will include postoperative pain, opioid consumption, functional recovery, and adverse events. The trial will also specifically examine the safety and feasibility of a higher-dose glucocorticoid regimen. Results aim to identify an optimized LIA dosing strategy to improve postoperative recovery and quality of life.
Why it matters
Potential benefit: If successful, the results could identify an optimal Diprospan dose for LIA that reduces pain, lowers opioid use, and speeds recovery after knee replacement.
How similar studies have gone: Previous randomized trials have shown that adding low-to-moderate doses of corticosteroids to local infiltration analgesia can reduce post-TKA pain, but the safety and efficacy of higher-dose Diprospan regimens remain less well studied.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Male or female participants aged 18 years or older; 2. Undergoing primary unilateral total knee arthroplasty (TKA)for unilateral knee osteoarthritis(OA)at ourhospital; 3. Preoperative American Society of Anesthesiologists(ASA)physical status classification of 1-3; 4. Ability to provide informed consent and sign a written informed consent form. Exclusion Criteria: 1. Previous surgery on the operative knee or a history of infection in the operative knee; 2. Non-osteoarthritis conditions (including rheumatoid arthritis, traumatic arthritis, septic arthritis, and hemophilic arthritis); 3. Severe osteoarthritis (including flexion contracture \>30° or varus/valgus deformity \>30°); 4. Allergy to the relevant study drugs; 5. Presence of neuromuscular dysfunction in the ipsilateral limb; 6. Dependence on anesthetic drugs (defined as weekly use of opioids exceeding 100 mg morphine equivalents or local anesthetics for preoperative pain control for more than 3 months); 7. Poor systemic condition, including but not limited to: glycated hemoglobin (HbA1c) level \>12%; blood pressure \>170/110 mmHg (1 mmHg = 0.133 kPa); history of myocardial infarction, stroke, transient ischemic attack, acute congestive heart failure, or any acute coronary event within 6 months; dialysis or renal transplantation; pregnancy or lactation.
Where it's running
-
The First Affiliated Hospital of Fujian Medical University
Fuzhou, Fujian, China Recruiting
Study contacts
- Study coordinator: Chaofan Zhang, PhD
- Email: drcfzhang@fjmu.edu.cn
- Phone: +86059187982113
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Tau changes after hip or knee replacement surgery
Researchers will see if brain tau changes after hip or knee surgery and whether these changes relate to inflammation and thinking abilities.
-
Ultrasound predictors of adductor canal block success after knee replacement
This study tests whether ultrasound factors can predict how well an adductor canal block will relieve pain after total knee arthroplasty in adults.
-
Rebound Pain After Knee Replacement: Does It Link to Long-Term Pain?
This study tests whether rebound pain after a nerve block during knee replacement is linked to developing chronic pain later on.
-
Comparing BiFeS and iPACK nerve blocks for pain after knee replacement
This trial will test if adding the BiFeS nerve block to an adductor canal block controls pain and reduces opioid use more than adding the iPACK block in people having total knee replacement.
-
Chlorhexidine antimicrobial incise drape for hip and knee replacement surgery
This will test a chlorhexidine antimicrobial incise drape to see if it reduces contamination during primary hip or knee replacement surgery.
-
Return to sports after knee replacement
This project will try stepwise, sports-style functional tests to see if people with knee replacements can safely return to their sport.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.